Phenobarbital for the management of severe acute alcohol withdrawal (the PHENOMANAL trial): a pilot randomized controlled trial

Abstract Background Benzodiazepines are considered first-line treatment for patients experiencing severe acute alcohol withdrawal syndrome (sAAWS). Although several medications have been evaluated as potential adjuvant treatments for sAAWS, barbiturates show particular promise. Objective In the PHEN...

Descripció completa

Dades bibliogràfiques

Autors principals:	Niall Filewod, Stephen Hwang, Christian J. Turner, Leena Rizvi, Sara Gray, Michelle Klaiman, Danielle Buell, Johnathan Ailon, Alexander Caudarella, Galo F. Ginocchio, Marlene Santos, Gyan Sandhu, Norman Dewhurst, Kelly Sequeira, Karen E. A. Burns
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2022-01-01
Col·lecció:	Pilot and Feasibility Studies
Matèries:	Phenobarbital; Alcohol withdrawal Delirium tremens Treatment
Accés en línia:	https://doi.org/10.1186/s40814-021-00963-4
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!